생체흡수성 임플란트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Bioresorbable Implants Market size is expected to reach USD 15.83 Billion in 2034 from USD 7.16 Billion (2025) growing at a CAGR of 9.21% during 2026-2034.

The Global Bioresorbable Implants Market is gaining momentum as medical technology advances toward more patient-friendly and minimally invasive treatment solutions. Bioresorbable implants are designed to gradually dissolve within the body after fulfilling their intended function, eliminating the need for surgical removal. These implants are widely used in orthopedic, cardiovascular, and dental procedures, offering improved patient comfort and reduced risk of long-term complications.

Market growth is driven by increasing demand for advanced medical implants and rising awareness about the benefits of bioresorbable materials. Innovations in biomaterials and polymer technology have enabled the development of implants that provide structural support during healing and then safely degrade within the body. Healthcare providers are increasingly adopting these solutions due to their ability to improve recovery times and minimize the need for follow-up surgeries.

The future outlook for the Global Bioresorbable Implants Market is highly promising as research continues to expand the applications of bioresorbable materials. Manufacturers are investing heavily in developing next-generation implants with enhanced strength, durability, and biocompatibility. Emerging markets are also expected to offer significant growth opportunities as healthcare infrastructure improves. As demand for advanced and patient-centric medical technologies rises, bioresorbable implants are expected to play a crucial role in modern surgical practices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Material Type

• Metallic
• Polymer

By Application

• Orthopedic
• Cardiovascular
• Others

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Abbott Laboratories, Medtronic plc, Johnson Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, Smith Nephew plc, Boston Scientific Corporation, Biotronik SE Co KG, Terumo Corporation, Arthrex Inc, Corbion NV, DSM Biomedical, W L Gore Associates Inc, Amaranth Medical Inc, Bioretec Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY MATERIAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Material Type
• 4.2. Metallic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Polymer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiovascular Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIORESORBABLE IMPLANTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Material Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Material Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Material Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Material Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Material Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIORESORBABLE IMPLANTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 Medtronic Plc
  • 9.2.3 Johnson & Johnson
  • 9.2.4 Stryker Corporation
  • 9.2.5 Zimmer Biomet Holdings Inc
  • 9.2.6 Smith & Nephew Plc
  • 9.2.7 Boston Scientific Corporation
  • 9.2.8 Biotronik SE & Co. KG
  • 9.2.9 Terumo Corporation
  • 9.2.10 Arthrex Inc
  • 9.2.11 Corbion N.V
  • 9.2.12 DSM Biomedical
  • 9.2.13 W. L. Gore & Associates Inc
  • 9.2.14 Amaranth Medical Inc
  • 9.2.15 Bioretec Ltd